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Abstract
Digital health innovations (DHIs) contribute to
improving the health sector by revitalizing availability
and continuity of care as well as mitigating rising
costs. DHIs getting increasing support from health
insurance companies and governmental institutions,
but still struggle on their way to standard care in
national healthcare systems. One of the central
challenges is the multitude of diffusion barriers, which
are either little known or difficult to handle in
complexity and therefore pose a high risk for the
translation into the healthcare practice. This paper
steps into this discourse with a design-oriented
research approach. A systematic literature review
identified DHI barriers that are further evolved to a
concept for assessing barrier resilience. On that basis,
a framework to systematically administer diffusion
barriers to DHI in Germany was developed.
Innovators may use the proposed framework to assess
the likelihood of a successful implementation and to
ensure smooth scaling up process of their DHI.

1. Introduction
Digital technology and the
United Nations
Sustainable Development Goals (SDGs) [1] are
interwoven on a variety of levels. One example of this
interplay is the third objective of the SDGs aiming at
health-related action areas in which digital technology,
in form of digital health, represents a significant element
to achieve the formulated sustainability goals [2], [3].
Restraining this connection, however, digital healthcare
solutions often face the scaling-up problem – a
phenomenon that describes how digital health
innovations (DHIs) are retained from finding their way
into standard care. Solutions that have a demonstrable
effect on care can frequently not unfold their benefits for
the general public. Recently, regulatory measures such
as the German Digital Healthcare Act show that political
decisions support the digital transformation of the health
sector and that digital health applications are
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acknowledged in care alongside medication [4].
Nevertheless, the basic problem remains: the complex
and regulated healthcare environment imposes a large
number of barriers to health innovations that are little
known, especially to smaller innovators, and thus
present a high risk to the successful development and
exploitation of DHIs [5]. Small and medium-sized
enterprises often struggle to identify such barriers and
miss out on taking appropriate mitigation measures
early on to ensure proper development and marketing of
their solutions [6].
Therefore, we present an evaluation approach to
support the early analysis and identification of possible
deficits in targeting propagation barriers. Thus, we help
to increase the accessibility of digital health applications
and thereby the availability of healthcare for
communities. Evaluation is used when informed
decisions are to be made. The evaluation approach in
this paper utilizes theoretical knowledge on propagation
barriers of health innovations. Practitioners benefit from
getting a concise outline of propagation-related
strengths and weaknesses of their DHI in key figures.
This can serve as a useful tool to develop sustainable
digital health solutions that keep up with high
expectations posed upon them and at the same time help
researchers to further investigate the phenomenon of the
scaling-up problem [7]. The design objective of this
article is therefore linked to the question:
What does an approach to assess the barrier
resilience of Digital Health Innovations look like?
A DHI in the context of this paper is the use of
information and communication technology to deliver
health or health-related services [3]. Nested in diffusion
theory [8] and scaling-up of innovations [9], this paper
builds on a body of preliminary work covering two
domains: (1) diffusion barriers of DHIs and
methodologies to reveal them as in analysing the lessons
learned of DHI projects [10] and providing generic
classifying taxonomies of DHI diffusion barriers [11];
and (2) a number of evaluation frameworks of DHIs.
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This paper complements recent initiatives to develop
DHI evaluation frameworks [12], [13] by adding a
categorization of existing evaluation approaches for
health innovations and deriving an assessment
framework from propagation barriers in healthcare. We
add to the existing literature by newly accumulating
knowledge from the two domains and providing an
artifact as an applicable implementation of theory as
design science [14]. The framework is exemplarily
made-to-measure the German healthcare environment
in order to show the applicability and utility of the
approach in a concrete healthcare market. Generally,
Germany can also serve as a representative example
among OECD states with Social Health Insurance, i.e.,
societal actors decide on regulations and financing while
services are largely provided by private for-profit actors
[15]. The final assessment, however, needs to be tailored
to the specific national context.
Starting with researching propagation barriers
focusing on DHIs in Germany, the identified corpus of
contributions centered around these barriers is
examined. Next, we present our methodology (Section
2) and provide an overview of existing evaluation
approaches (Section 3). Based on that, an assessment
approach tailored to the German healthcare environment
is designed (Section 4). The resulting framework is
tested using an exemplary project in the German
healthcare market with a phenotypical character for
DHIs (Section 5). The paper closes with a discussion of
the results (Section 6) and concluding remarks as well
as an outlook on further research (Section 7).

2. Methodology
The methodological approach is based on the
Design Science Research (DSR) principles [16] and
aligned with a DSR process (DSRP) model [14]. The
relevance and problem identification (DSRP Phase 1) as
well as the design objective (DSRP Phase 2) was
elaborated in Section 1. The artifact is constructed in
multiple steps (DSRP Phase 3) as follows: In order to
comply with DSR-guidelines and to ground the research
on rigorous practices, a systematic literature search was
carried out to accumulate literature broaching the issue
of diffusion barriers in healthcare [17]. Based on this,
the research results were analyzed using inductive
category formation by Mayring to identify propagation
barriers of DHIs in general and specific barriers in
Germany [18]. Next, existing approaches to evaluating
digital health solutions were identified in a second
literature search. To map the ground covered by
preliminary research, a taxonomy was created helping
to categorize existing DHI assessment approaches [19].
The categorization revealed an existing artifact that is
iterated to fit the needs of an evaluation tool synthesized

for the German environment [20]. Finally, this paper’s
framework is applied (DSRP Phase 4) and evaluated
(DSRP Phase 5) using a practical example.
Identification of propagation barriers. In order to
identify existing literature on propagation barriers in the
German healthcare system, scientific databases were
searched for relevant contributions on August 4, 2018
[17], [21]. The search term consisted of three elements
to which synonyms in German and English were added:
(1) barriers (obstacles, hurdles, resistance, etc.), (2)
propagation mechanisms (scaling-up, translation,
diffusion, etc.) and (3) digital health innovations
(eHealth, telemedicine, telehealth, etc.). The search
queries were applied to the databases EBSCOhost,
ScienceDirect, IEEE Xplore, SpringerLink, PubMed
and AIS Electronic Library (+368). Duplicates, nonEnglish and non-German contributions as well as
contribution types such as dictionary entries and
announcements were removed from the corpus (-158).
From the remaining publications, relevant contributions
were selected on the basis of an inclusion criterion,
which was checked against the respective abstract [22],
[23]. The inclusion question was: Are barriers to the
spread of digital solutions in the healthcare system or
the basic parameters for digital innovations in the
German healthcare system being investigated? (-191).
In a final acquisition step, this selection was subjected
to a backward reference search (+3). One publication
was not accessible (-1), creating an overall literature
corpus of 21 publications.
Inductive category formation is used to map the
material on propagation barriers distortion-free [18].
For the first step of the category formation, the aim of
the process has to be defined. The aim is to extract the
barriers to propagation of DHIs in the German
healthcare system from the body of literature, consisting
of 21 publications. Next, a selection criterion will be
defined to determine which passages of text are used to
induce the formation of categories. If sections are found
that can be assigned to the selection criterion, the first
category is formulated as close as possible to the text
formulation and confirm to the level of abstraction.
Further categories are formed from the following text
passages that fit into the selection if they can not be
subsumed under existing categories. The categories are
revised in an intermediate step before the material is
completely worked through and the categorization can
be interpreted. The result is depicted in Table.1.
Analysis of existing assessment approaches. A
second systematic literature search was carried out to
record the state of research on evaluating the spread of
digital health solutions on November 12, 2018 [17],
[21]. Into this search, both, scientific contributions
(+225) and grey literature (+20) were included. The
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Table.1 Categories of propagation barriers
Super-categories

Categories and selected references
Remuneration conditions cross-sectoral; Remuneration conditions in the stationary sector;
(1) Reimbursement and
Reimbursement in the outpatient sector; Non-remuneration of cost savings; Infrastructure
Financing
costs; High initial costs; Low willingness to pay on the second healthcare market [19]-[23]
Health market approval conditions; Legal data protection regulations; Lack of standardised
(2) Regulations and Guidelines regulations: Liability risks; Ban on remote treatment [19]-[21], [24]
Technical maintenance; Infrastructural barriers; Lack of security/reliability of medical data;
(3) Technical Barriers
Lack of technical interoperability/compatibility [19]-[22]
(4) Proof of Effectiveness

Deficit in studies; Missing certification method; Lack of evidence of efficacy; Lack of
evaluation methodology [20]-[23]

(5) Proof of Efficiency

Lack of efficiency evidence; Duration of efficiency assessment [23]

(6) User Acceptance

Knowledge and competence-related barriers; Insufficient relative advantage; Necessary
process changes; Resistance of the practitioner to changes in established practices; Questions
of trust towards the provider; Unsuitable organizational structure of the adopters;
Stigmatization of the patient; Reading/spelling deficit of the patient; Conservative attitude of
physicians towards innovations; Lack of technical affinity or knowledge among physicians
and patients; Fear of job loss on the part of the physician [19]-[22],[25]-[27]

search queries combined (1) types of digital health
innovations (eHealth, telemedicine, etc.), (2) artifact
types (framework, model, etc.) and (3) an element
related to evaluation (quality management, evaluation,
etc.). The search was carried out in the scientific
databases PubMed, ScienceDirect, EBSCOhost and
SpringerLink, as well as for grey literature with the
search engine Google. Contributions were selected
qualitatively for closer examination (-218). A forward
reference search revealed additional relevant literature
(+4). The second literature corpus, consisting of 31
publications, was categorized using a taxonomy to get
an overview of the scope of preliminary work at
transparent standards [19].
Synthesis of the DHI assessment approach.
Investigating existing evaluation approaches of digital
health innovations, revealed that no distinct tool helping
to address propagation barriers in the German healthcare
system exists. This paper sets out to fill the lack of a
Germany-centered solution to help practitioners
dispatch propagation issues of their health innovations.
Therefore, an evaluation sheet will be developed to
assess how effectively barriers to the spread of digital
health applications were dealt with. Since the draft to be
designed contains an evaluation aspect, the Roadmap
for Planning an Evaluation Concept for the Area of EHealth is used for the development of the artifact [24].
Complying with DSR-guidelines, the approach is finally
demonstrated and evaluated [16].

3. Status of research
Research on the propagation barriers as well as
evaluation approaches for DHIs already exist. This

section presents an overview of these publications and
derives barriers under consideration in this article from
the literature base. Afterward, existing assessment
frameworks are scrutinized according to their ability to
suit the requirements imposed by the environment the
German healthcare system operates in.
Identification of barriers to the spread of digital
health innovations in Germany. Based on the first
literature search, propagation barriers for innovations
are identified through inductive category formation.
Since the formed categories shall reflect propagation
barriers, the selection criterion is: Propagation barrier
for digital health innovations that are unique to the
healthcare context and can be transferred to the
German context. Categories that specifically refer to a
non-German context are not formed (e.g. barriers from
guidelines in sub-Saharan Africa). Thus, 33 categories
were identified. In summary, six super-categories were
formed (see also Table.1 for details):
(1) Reimbursement and Financing relates to
barriers associated with monetary and budgeting issues
as well as reimbursement of digital solutions in the
public healthcare system [11], [25]–[28]. (2)
Regulations and Guidelines sum up hurdles posed by
statutory compulsions that have to be complied with
[11], [25], [26], [29]. (3) Technical Barriers originate in
technological restrictions or difficulties [11], [25]–[27],
while (4) Medical Proof of Effectiveness confirms the
medical properties of an innovation in healthcare [11],
[26]–[28]. (5) Economic Proof of Efficiency
encompasses issues around validating the return of
investment of an innovation. [28] (6) User Acceptance
focuses on social and organizational factors influencing
the propagation of DHIs [11], [25]–[27], [30]–[32].
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Mapping of existing DHI assessment
approaches. Subsequently, a taxonomy was created to
categorize the preliminary work containing evaluation
approaches of DHIs. The aim is to find out to what
extent the mentioned barriers to propagation have
already been considered in evaluations of other authors.
The taxonomy was created in seven iteration steps,
resulting in seven taxonomy dimensions [19].
The first iteration distinguishes whether a
contribution is applicable to a practical problem
(Concrete), or whether it is a draft, a requirements
analysis, a naming of critical factors, a recommendation
or a plea for evaluation (Abstract). The second iteration
differentiates between objects under consideration
along the span of DHIs, as described in Otto et al. 2018.
Iteration number three distinguishes between the
intended geographical sphere of influence of the
contribution (Global/No Specification, Developed NonEU Country, Developing Country, EU, Non-German
EU-country and Germany). The next iteration creates a
dimension to document the extent to which a
contribution addresses the propagation barriers earlier
identified with inductive category formation. The fifth
iteration differentiates whether a contribution considers
the overall quality of an intervention concept (Quality of
the Intervention Concept), whether it supports an
increased spread of the intervention (Diffusion Related),
whether it focuses on the condition of an innovation
(State Evaluation) or the successful implementation of
the intervention (Successful Implementation). Iteration
number six distinguishes whether an evaluation
approach makes a summary statement (Summative),
whether it is conducted in parallel to an implementation
of the measure and influences it (Formative), or whether
a contribution explores evaluation abstractly and no
statement can be assigned to the mode (e.g. a plea for
alignment of evaluation with certain standards, Too
Abstract for a Mode) [18]. The last iteration categorizes
contributions proposing or delivering a quantitative
(Ordinal) or a qualitative (Nominal) evaluation result. A
publication under consideration may be too vague to
make a statement about the evaluation result (Too
Abstract for a Result). The resulting taxonomy
displaying the identified dimensions and characteristics
is depicted in Table.2.
The taxonomy was applied to describe and
categorize 31 identified assessment approaches in the
second literature search (Section 2 Analysis of existing
assessment approaches). The results reveal that so far,
no contribution has been made that allows assessing
which propagation barriers were being addressed by a
DHI in the context of the German healthcare system.1

That implies that only little guidance exists for
practitioners in this field to support development efforts
and make a DHI fit for seamless spread. Therefore, an
adequate evaluation approach is developed in the next
section.

4. Synthesizing the evaluation approach
An evaluation approach helps stakeholders to
assess the extent to which potential for scaling-up an
innovation is being exploited and supports with
recommending measures for successful market
diffusion. This goal is worked towards in this section by
synthesizing an evaluation approach that offers the
opportunity to gather propagation barrier-related
information about DHIs systematically and produce
quantitative results indicating the innovation’s barrier
resilience [24]. The approach is designed in accordance
with the evaluation standards Usefulness, Feasibility,
Fairness and Accuracy [33].
For the artifact design, an existing scoring system
will be altered and refined as intended in a DSR-artifact
iteration [16]. This scoring system originally is the
backbone of the MAPS-Tool (mHealth Assessment and
Planning for Scale, WHO 2015), a framework
examining mHealth-solutions focussing on their
suitability for scaling-up along defined categories (Axis
of Scale). Each category contains several globally
applicable questions on the measures taken to achieve
scaling goals. The quantification system that was
employed is a four-stage point system.
Each category is rated depending on the response
option picked by the surveyor: No (0 points), In
Progress (1 point), Executed (2 points); Documented (3
points) or Not Applicable (3 points). Non-fulfillment
(No) expresses the previous disregard of the barrier
aspect and is thus interpreted negatively. From there the
rating increases leading to the documented
confrontation with barriers (Documented), relating to
testified efforts being made, and thus scores highest due
to its traceability. If questions are not applicable, they
are assessed positively to avoid influencing the overall
picture unfavorably. Since five criteria are asked for
each barrier, each of which is evaluated with up to three
points, the evaluation sheet is based on a 15-point
system. The modification of the MAPS-Tool concerns
the frame of reference of the evaluation, which is
alienated from generic global criteria and finds its
unique feature compared to other approaches through
the special reference to German propagation barriers.

1

The complete list of analyzed assessment approaches and results of
applied taxonomy will be provided as an additional data source.
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Table.2 Taxonomy of existing evaluation approaches for digital health innovations
Dimensions
Level of
Abstraction
Object of
Reflection
Regional
Limitation
Aspect of
Consideration
Context of
Consideration
Mode
Scale of Results

Characteristics
Concrete
eHealth
Global/No
Specification

Abstract

Telemedicine
Developed
Non-EUCountry

Telehealth

Developing
Country

mHealth
EU

Non-German
EU-Country

Digital Health
Germany

Reimbursement
Regulations and
Technical
Medical Proof Economic Proof
User
and
Guidelines
Barriers
of Effectiveness of Efficiency
Acceptance
Financing
Quality of the
Successful
Diffusion Related
Status Evaluation
Intervention Concept
Implementation
Summative
Formative
Too Abstract for a Mode
Ordinal
Nominal
Too Abstract for a Result

Furthermore, it is made applicable for every kind of
DHI, including mHealth, telemedicine, telemonitoring,
eHealth and alike [10]. Thus, a thorough analysis of the
German healthcare system was conducted along the
barriers for DHIs to concretize the six super-categories
in appropriate assessment items. The adaptation of the
following assessment approach to other national
specifications requires an appropriate adjustment of this
step of analysis and design.
(1) Reimbursement and Financing was covered
with an analysis of possibilities for reimbursement in the
ambulant and stationery sector as well as the
intersectoral reimbursement.
(2) Regulations and Guidelines incorporate
findings related to the E-Health-Law (SGB V), like the
registration of DHIs in the a public online
interoperability register (gematik’s vesta information
portal [34]), as well as data security regulations
(DSGVO/GDPR), laws regarding medical products
including Conformité Européenne (CE) certification,
and IT security regulations with policies for critical
infrastructure (KRITIS).
(3) Technical Barriers were considered including
technical (HL7, DICOM, xDT) and semantic
communication standards (OPS, ICD, SNOMED CT,
LOINC) as well as technical security requirements for
medical devices (93/42/EWG) and data security
considerations (§ 64 BDSG). Additionally, transmission
technology and special user needs have to be
considered.
(4) Proof of Medical Effectiveness contains
measures assuring compliance with the principle of
evidence-based medicine in the public healthcare
system, the role of clinical trials (93/42/EWG) and
peculiarities of health technology assessments (HTAs).

(5) Economic Proof of Efficiency encompasses
actions towards the efficiency command (§ 12 SGB V)
in the German public healthcare system and variations
of health-economic analysis as well as cost types to
prove equal or better care provision for lower costs.
Finally, (6) User Acceptance utilized the
Technology Acceptance Model to analyze patient and
practitioner needs [35]. The resulting assessment form
can be seen in Table.3. The scores for the aspects in
question can be documented in the left column.

5. Demonstration
The newly developed artifact will be demonstrated
on a phenotypical digital health solution with a user base
in Germany. The case study is based on the application
mySugr: your intelligent diabetes diary. Among the
functions of mySugr2 are collecting and graphically
processing information on diabetes (e.g. blood sugar,
meals, medication, physical activities) in the form of a
diary to optimize therapy outcomes and mitigate the
course of the disease [36].
1) Reimbursement and Financing. mySugr is a
medical device and therefore belongs to the first health
market [37]. The app is available in a free basic version
and can be extended in its functions by using a version
with costs. Since April 2018, some private health
insurance companies reimbursed the costs for using the
application [38]; from July 2018, this was also offered
by a selection of public health insurance companies.
Various financing models of the public and private
sectors were considered, implemented and documented.
Patient-financed, as well as health insurance-financed
models, are available. Score: 15

2

Information about mySugr has been collected from company
websites. Details may differ due to national specifications.
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Possibilities of remuneration through selective contractual remuneration within the public healthcare system were considered.

Possibilities of direct contractual remuneration by a statutory or private health insurance were considered.

Financing models for remuneration from private demand on the secondary health market were considered.

The benefits and risks of the financing models were evaluated and included in transition plans.

2) Regulations and Guidelines

Scenarios for the innovation’s application are designed in such a way that service providers do not risk violating the ban on remote treatment.

Data protection rules were taken into account when designing the application.

It was examined whether the application falls under the regulations of the Medical Devices Act and measures were taken accordingly.
It was checked whether the application is part of critical infrastructure (KRITIS) and the design of the application was planned according to the legal
requirements.
The registration in the vesta information portal was carried out and it was examined to have used standards included in the lists of the gematik.

F2

F3

F4

F5

#

F6

F7

F8

In order to achieve interoperability, the need to comply with technical standards was reviewed and, if necessary, implemented.

It was examined whether the latency caused by the technical infrastructure used does not restrict the usability of the application.

The application is designed in such a way that user-specific requirements have been implemented.

F13

F14

F15

The approval of the responsible authorities and commissions was obtained for the preparation of the medical proof of efficacy.

It was examined whether the current state of studies is sufficient to prove the medical effectiveness, in order not to endanger the remuneration model.

Information on the testing mechanisms and times is available and it is planned in such a way that it does not endanger the business model.

F18

F19

F20

Various cost aspects (direct, indirect, intangible costs) were taken into account in the preparation of the economic efficiency report.

It was examined whether the study situation is sufficient to prove the economic efficiency in order not to endanger the remuneration model.

The evaluation design of the economic proof of effectiveness was chosen in such a way that the interests of the addressee are taken into account.

F23

F24

F25

The fulfilment of the special needs of the user groups is clearly communicated.

Training measures are prepared for initial and further user training and resources are provided for implementation.

Measures have been taken to counteract possible stigmatisation of users.

Support for the processing of user queries are available.

Measures have been taken to simplify the integration of the application into the daily supply routine.

F26

F27

F28

F29

F30

6) User Acceptance

When preparing the evidence, measures were taken to exclude the risk of the result being jeopardised by difficulties with data collection.

F22

#

Evidence of the economic efficiency of the application has been produced.

F21

5) Economic Proof of Efficiency

It was examined whether a medical proof of efficacy must be carried out for the approval of the application and if necessary arranged.

F17

#

Evidence of the medical efficacy of the application has been provided.

F16

4) Medical Proof of Effectiveness

The application is designed in such a way that compliance with legal security regulations cannot be questioned.

F12

#

The application and the infrastructure are designed in such a way that an infringement of personal data protection rights can be ruled out.

F11

#

F10

3) Technical Barriers

Possibilities for reimbursement within an examination and treatment method in the public healthcare system were considered.

F9

1) Reimbursement and Financing

#

F1

0

0

0

0

0

No

0

0

0

0

0

No

0

0

0

0

0

No

0

0

0

0

0

No

0

0

0

0

0

No

0

0

0

0

0

No

1

1

1

1

1

Progr.

1

1

1

1

1

Progr.

1

1

1

1

1

Progr.

1

1

1

1

1

Progr.

1

1

1

1

1

Progr.

1

1

1

1

1

Progr.

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

2

2

2

2

2

3

3

3

3

3

Exec. Doc./NA

2

2

2

2

2

Exec. Doc./NA

2

2

2

2

2

Exec. Doc./NA

2

2

2

2

2

Exec. Doc./NA

2

2

2

2

2

Exec. Doc./NA

2

2

2

2

2

Exec. Doc./NA

Table.3 Assessment form for DHI-applications
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2) Regulations and Guidelines. The application is
designed as a tracker and diary of diabetes data and does
not include remote treatment functions [39]. mySugr
ensures compliance with various data protection
guidelines in the data protection declaration [40]. In
addition, the app is approved as a Class I medical device
(one module as Class II). The application is not critical
infrastructure so that special requirements for KRITIS
do not apply. Deductions apply because mySugr is not
registered in the vesta Informationsportal. Score: 12
3) Technical Barriers. The technical design of the
diabetes tracker for the protection of personal data is
reassured in company statements [41], with reference to
the use of the Amazon Web Services cloud infrastructure
and its certificates and compliance with standards and
guidelines. The security design is again proven by the
CE conformity of mySugr. The application is
interoperable with various blood glucose monitoring
devices [39]. The transmission of larger amounts of data
does not result from the application’s use cases so that
latency times do not have to be considered. The user
ratings confirm that the app mostly fulfills user-specific
requirements [43]. Number of points: 13
4) Medical Proof of Efficacy. The medical
efficacy of mySugr has been demonstrated and
published [44], [45]. Thereby, the present state of
studies was improved, and the reimbursement model
was backed-up with clinical data. Testing times and
mechanisms did not pose a lasting threat to the existence
of the project. Score: 15
5) Economic Proof of Efficiency. Support from
investors for the development team indicates proved
efficiency. Financing rounds between 2014 and 2015
ended with a monetary backing of several million euros
[46] and culminated in the takeover by Roche in 2017
[47]. Score: 15
6) User Acceptance. The application is specifically
designed to meet the documentation needs of diabetics.
Despite the very good ratings on Google Play, there are
hints from users in the comments about the app's
inadequacies [43]. The mySugr website offers training
courses on how to use the app [48]. Stigmatization of
users is prevented with a humorous character of
application and the creation of a sense of community in
the user base through blog entries and newsletters.
Support is available on a variety of channels [49].
Studies were conducted to measure user satisfaction, in
which the application was rated positively [50]. Score:
13

(1)
(6)

(2)

(5)

(3)

(4)

Figure 1. Visualization scoring “mySugr”
The demonstration showed that the presented
approach to propagation barrier assessment is applicable
to a popular DHI that is used on the German market. It
helps to analyze which hurdles imposed on DHIs by the
German healthcare system were addressed by mySugrdevelopers and which would still need some attention in
order to speed up the spread of the application and reach
a higher volume of users.

6. Discussion
Based on the results of the former sections, the
designed assessment approach is evaluated with respect
to the standards of the German association for
evaluation [33]. Usefulness. The result of the
assessment of mySugr coincides with the actual
successful propagation development of the application.
The next step would be to examine low scored areas and
take measures to address under-considered barriers.
Whether those measures lead to practice-relevant
changes for the application could not be clarified in the
demonstration. However, the evaluation remains a
visible confirmation for outsiders reflecting the strong
positioning of mySugr, which presents a benefit.
Feasibility. The feasibility of the assessment largely
depends on the robustness of the information base for
the solution under consideration. In the case of mySugr,
the company’s tendency to openly communicate with its
userbase contributed to a highly feasible assessment.
However, with the knowledge of a company insider,
statements could have been made more accurately.
Fairness. Measures must be taken to ensure that all
information necessary for an assessment is available to
all stakeholders at all times, i.e. that assessments of
solutions take place under the same (fair) conditions for
third parties. One possibility could be to access
standardized data for assessment in the vesta
Informationsportal, although it is often provided
insufficiently. In order to preserve the feasibility of an
evaluation to cover the full range of DHIs, fairly generic
evaluation questions had to be used which could have
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compromised the accuracy of the evaluation of an
mHealth application. Accuracy. The assessment of
mySugr resulted in an overall positive score indicating
that most of the propagation barriers were addressed and
dealt with, which is reflected in the successful market
dissemination of the app. However, compromises had to
be made regarding the assessment parameters (No, In
Progress, Executed, Documented/Not Applicable).
They are not linked to the quality of a measure taken and
its sustainable effectiveness, which affects the effective
barrier resilience of an application. Therefore, more
resilient metrics for the assessment of barrier aspects
have to be introduced.
This article contributes to diffusion and
adoption research in healthcare. It offers insides into
the aspects of healthcare-specific diffusion barriers by
integrating former research in the area and applying a
distinct focus on the German environment. The resulting
categorization offered a frame for investigating the
German healthcare system under more narrow thematic
limitations. Additionally, a review of preliminary
research on healthcare innovation barriers was provided.
These two preparatory steps lead to the design of an
easy-to-use approach to assess the readiness of an
innovation to successfully spread. Usefulness and
functionality of DHI play only a secondary role in this
approach. Sustainable value is rather added by shifting
from
functionality-focused
thinking
towards
dissemination-centered considerations. Summarizing
this paper’s scientific relevance: it enriches existent
knowledge about DHI diffusion into healthcare markets
by a formative assessment method that allows the
determination of how a DHI may take the hurdles of
concrete diffusion barriers. In a broader sense, the
presented measures imply design principles of DHI.
The presented artifact is aligned with the EU
interoperability framework. The proposed evaluation
approach supports innovators and development teams
struggling with the complexity of DHI diffusion into
day-to-day healthcare. As interoperability is considered
highly relevant to ensure DHI diffusion success,
research and consensus processes of eHealth Network (a
task network of the European Commission) led to the
Refined European Interoperability Framework (ReEIF)
in 2015 as a general definition for eHealth
interoperability. The contribution of this paper is
aligned with this consensus as categories and supercategories address the six interoperability levels of
ReEIF (Legal and regulatory; Policy; Care Process;
Information; Applications; IT-Infrastructure) [51].
Thus, the proposed assessment approach breaks down
the complexity of DHI diffusion while offering an aid
kit for struggling innovators.

The presented artifact is also subject to
limitations. One limitation results from the
methodology of the literature-based research approach
deriving barriers with inductive category formation.
This practice results in categories formed on the one
hand regardless of contemporary significance, on the
other hand relying on the assumption that relevant
barriers were already being discovered in preliminary
research. Thus, it can not be guaranteed that the barriers
found have practical relevance, which requires research
in the field and can be worked on by conducting expert
interviews. Additionally, the categories that were
formed and represent propagation barriers exist in de
facto interdependence but were considered as being
separate in this paper. That could lead to false
compartmentalization of the healthcare system during
the attempt to create the assessment approach. Another
basic potentially misleading assumption was created
around the unified understanding of the terminology
summed up in the term digital health during the research
on existing evaluation frameworks. Thus, subsequent
categorizations of named approaches might have
suffered from ambiguity. Furthermore, the evaluation
revealed that the quality of the information fed into the
assessment model is pivotal for the assessment outcome.
Hence the reliability of the information used in the
artifact application has to be ensured. Moreover, proof
is required that the assessment approach followed by the
scoring system does indeed support hands-on decision
making. This is especially true, since the descriptions of
the healthcare environment the assessment is based on,
was only briefly broached and is currently not to the
innovator’s disposal in case a category scored low.
Finally, the frame in which this approach to DHI
assessment is tailored to is currently limited to the
German healthcare context. That limitation was
necessary to create a usefully specific, manageable
framework in the first place, seeing the German
healthcare system as fairly homogeneous. Since that
focus was set in such an early stage of research, the
migration of the assessment framework to another
region might require fundamental content changes early
on. However, the methodology would be just as
applicable and an expansion to other OECD member
states with Social Health Insurance [15] might require
slight modifications only.

7. Conclusion
This paper discussed a central issue of digital health
innovations – even highly optimized DHIs with strong
problem-solving potential do not necessarily scale-up in
the intended environment. A crucial factor for that are
system-imposed barriers that have to be taken into
consideration to introduce innovations to end-users and
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unfold expected benefits for care provision. To tackle
this issue, a first draft of an evaluation approach was
developed to determine the resilience of DHIs to
propagation barriers in the German healthcare system.
Apart from improving the approach by additional
research on the limitations, the assessment can be
extended to a stakeholder perspective by linking
propagation barriers to corresponding interest groups in
the healthcare system. These interest groups often have
contradicting goals and different levels of influence on
DHI-diffusion success. Thus, the extension would
benefit the overall approach by weighting barriers
stakeholder-sensitively which adds more accuracy to the
scoring. In practice, the presented approach could be
implemented as an evaluation tool on a platform for
digital health solutions using the already available
ordinal scoring or adding a nominal dimension,
describing addressable barrier aspects based on the
assessment in greater detail. Such services could either
provide guidance to developers working on DHIs or
assist with investment decisions into promising
innovations. Thus, the approach introduced in this paper
can contribute to using scarce resources in healthcare
more sustainably.
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